Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/23/2005EP1047397B1 Topical compositions for enhancing glutathione production
03/23/2005EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
03/23/2005EP1032398B1 Treating postmenopausal women using ultra-low doses of estrogen
03/23/2005EP0973886B1 Method and conjugate for treating helicobacter pylori infections
03/23/2005EP0938323B1 Treatment of highly vascular tumours with dextrin sulfates
03/23/2005EP0845005B1 Traf inhibitors
03/23/2005EP0832241B1 Mutants of streptococcal toxin a and methods of use
03/23/2005EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein
03/23/2005EP0723398B1 Superoxide dismutase mimetics
03/23/2005EP0574579B1 Dna encoding a human 5-ht 1f receptor and uses thereof
03/23/2005CN1599792A Nutrient medium for maintaining neural cells in injured nervous system
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599744A Beta -2'-or 3'-halonucleosides
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599736A Process for the preparation of 4-(8-chloro-5, 6-dihydro-11h-benzo(5, 6)-cyclohepta-(1, 2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine)
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599733A N-ureido-piperidines as antagonists viii for CCR-3 receptor
03/23/2005CN1599731A Benzothiazepine derivatives
03/23/2005CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
03/23/2005CN1599729A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/23/2005CN1599728A 1, 2, 4-triazole derivatives containing a sulphamate group as aromatase inhibitors
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599725A Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
03/23/2005CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
03/23/2005CN1599722A 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
03/23/2005CN1599721A CCR-3 receptor antagonists VII
03/23/2005CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr)
03/23/2005CN1599718A Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
03/23/2005CN1599717A Cyclic diamine compounds having fused-ring groups
03/23/2005CN1599716A Aminoacetonitrile derivatives and their use for controlling parasites
03/23/2005CN1599715A Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
03/23/2005CN1599629A Resorbable polymer composition, implant and method of making implant
03/23/2005CN1599625A Use of an h1 antagonist and a safe steroid to treat rhinitis
03/23/2005CN1599623A Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/23/2005CN1599622A Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1599617A Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
03/23/2005CN1599615A Oral immunostimulation of mammals, birds, and reptiles from (1-4) linked beta -d-mannuronic acid
03/23/2005CN1599614A Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599612A Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
03/23/2005CN1599611A Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
03/23/2005CN1599610A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2, 4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1, 4'bipiperidine as ccr5-antagonists for the treatment of aid
03/23/2005CN1599609A Combination of a selective PDE4 inhibitor and an adrenergic beta-2 receptor agonist
03/23/2005CN1599608A Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
03/23/2005CN1599605A Pharmaceutical compositions and methods for administering EP2 receptor selective agonists
03/23/2005CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
03/23/2005CN1599603A Method of stabilizing reduced coenzyme Q10
03/23/2005CN1599602A Peroxisome proliferator activated receptor ligands and process for producing the same
03/23/2005CN1599600A Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
03/23/2005CN1599599A Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
03/23/2005CN1599598A Controlled release polymeric compositions of bone growth promoting compounds
03/23/2005CN1599564A Oral immunostimulation of mammals, birds, fish and reptiles from 1-4 linked ss-d-mannuronic acid
03/23/2005CN1597701A Beta dextran preparation extracted from highland barley and its composition
03/23/2005CN1597694A Meningococcal antigens
03/23/2005CN1597689A Ledebouriella root glycoside and its preparation and application
03/23/2005CN1597677A Compounds and methods for modulation of estrogen receptors
03/23/2005CN1597676A Jujube kernel saponin derivative and its preparation method and use
03/23/2005CN1597674A 1, 3-di[N-(2-methoxy) phenyl] piperazine]-1- acetone hydrochloride and its preparation method and application
03/23/2005CN1597673A Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
03/23/2005CN1597671A Quinazoline deriative and preparation method and bioactivity
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1597662A A kind of aromatic acid amide compound its preparation method and use
03/23/2005CN1597656A Eugenol ibuprofen ester medical compound and its preparation and preparation method
03/23/2005CN1597008A Local preparation containing poloxamer and other microbe killing agent and applicator
03/23/2005CN1596920A Medicinal composition for treating cardiopathy and its preparation method and use
03/23/2005CN1596908A Sterilization bacteria inhibition compound iodophor medicine and its preparation and preparation technology
03/23/2005CN1596907A Use of bamboo leaf flavone in preparation of medicine or health-care food for preventing or treating thrombus disease or blood deficiency disease
03/23/2005CN1596906A Drip pill containing erigeron breviscapus and its preparation method
03/23/2005CN1596905A Erigeron breviscapus dispersion tablet
03/23/2005CN1596904A Medicine for regulating nerve system, treating epilepsia disease
03/23/2005CN1596903A Bean curd fruit glycocide softcapsule
03/23/2005CN1596902A Notoginseng total saponin intestine soluble type preparation
03/23/2005CN1596901A Ledebouriella root extract preparation used for treating climacteric syndrome and preparation method
03/23/2005CN1596900A Rusco saponin element and application of its saponin in preparation of medicine preventing and treating embolus disease
03/23/2005CN1596899A Dexamehasone palmitate freeze-dried emulsion and its preparation method
03/23/2005CN1596898A Biammonium glycyrrhizate powder-injection and its preparation method
03/23/2005CN1596897A Itraconazole injection and its preparation method
03/23/2005CN1596896A Aminochlorodipin, irbesartan compound preparation
03/23/2005CN1596895A Kusnezoff monkshood root methyl element microcapsule and its production method
03/23/2005CN1596894A Use of berberine as anti fungus medicine synergist
03/23/2005CN1596893A Cimetidine freeze-dried powder-injection and its preparation method
03/23/2005CN1596892A Use of abedol in preparation of medicine for preventing and treating hepatitis B, HIV virus
03/23/2005CN1596891A Preparation method of captopril compounding chitin polysaccharide slow release micro ball
03/23/2005CN1596890A Medicine having antivirus action
03/23/2005CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method
03/23/2005CN1596888A Application of dihydromyricetrin
03/23/2005CN1596887A Application use of dihydromyricetrin
03/23/2005CN1596886A Application of albi multisulfoxide and its salt in preparing medicine for preventing and treating respiratory tract virus infestation
03/23/2005CN1596885A Propyl gallate freeze-dried powder-injection and its preparation method
03/23/2005CN1596884A Composition containing high content conjugated linoleic acid and its preparation method
03/23/2005CN1596883A Compound dichloroacetic acid diisopropylamin powder-injection and its preparation method
03/23/2005CN1596882A Vitamin K1 emulsion and its freeze-dried emulsion and preparation method
1 ... 4747 4748 4749 4750 4751 4752 4753 4754 4755 4756 4757 4758 4759 4760 4761 4762 4763 4764 4765 4766 4767 ... 7860